发明名称 |
Methods of diagnosis and treatment of interstitial lung disease |
摘要 |
The present invention provides for a method of treating pulmonary disease in a subject comprising the administration to a subject in need of such treatment a therapeutically effective amount of a formulation comprising a SP-C therapeutic. Preferably, the SP-C therapeutic is an agent selected from the group consisting of an isolated SP-C protein, an isolated nucleic acid molecule encoding a SP-C protein, a SP-C receptor-specific antibody that stimulates the activity of the receptor, or pharmaceutically acceptable composition thereof. The present invention also provides methods of producing a mouse with a targeted disruption in a surfactant protein C (SP-C) gene. The present invention also provides for a transgenic mouse produced by a targeted disruption in a surfactant protein C (SP-C) gene. The present invention further provides for a cell or cell line from a transgenic mouse produced by a targeted disruption in a surfactant protein C (SP-C) gene.
|
申请公布号 |
US2005125851(A1) |
申请公布日期 |
2005.06.09 |
申请号 |
US20030731465 |
申请日期 |
2003.12.09 |
申请人 |
CHILDREN'S HOSPITAL RESEARCH FOUNDATION |
发明人 |
WHITSETT JEFFREY A.;GLASSER STEPHAN W. |
分类号 |
A01K67/027;A61K38/17;G01N33/50;(IPC1-7):A01K67/027 |
主分类号 |
A01K67/027 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|